News & Resources

RSS Content

Orexigen Therapeutics to Provide Business Update at the 2017 BIO Investor Forum

SAN DIEGO, Oct. 12, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that management will present at the 2017 BIO Investor Forum on Tuesday, October 17th, at 9:15 AM PDT (12:15 PM EDT).

Investors, analysts, and the general public are invited to listen to the presentation via webcast, which can be accessed on the "Investors" section of the Orexigen web site at The webcast will be archived and available for replay for 14 days following the call.

Orexigen Investor Contact:
Jason Keyes, Chief Financial Officer
+1-858- 875-8600

Orexigen Media Contact:
Erika Hackmann


View original content:

SOURCE Orexigen Therapeutics, Inc.